Skip to main content

1 Result(s)

within É. KÁnitz Remove this filter

and

  1. No Access

    Article

    Phase II study of 4′-Epi-Doxorubicin in patients with untreated, extensive small Cell Lung Cancer

    The purpose of the study was to investigate the antitumour activity and toxicity of high dose (120 mg m-2) single agent epirubicin therapy in untreated extensive small cell lung cancer patients. Out of 80 patient...

    S. Eckhardt, K. Kolaric, D. Vukas, É. KÁnitz… in Medical Oncology and Tumor Pharmacotherapy (1990)